(Press-News.org) The EORTC will present nine abstracts at the ASCO 2014 Annual Meeting which will be held 30 May – 03 June 2014 in Chicago, Illinois. Four abstracts will be presented in Oral Abstract Sessions, one in a Poster Highlights Session, and another four in General Poster Sessions.
Oral Abstract Sessions
Abstract # 4500
Monday, 02 June, 9:45 – 9:57, E Hall D1
Cora N. Sternberg, Iwona Skoneczna, J.M.Kerst, Sophie Fossa, Peter Albers, Mads Agerbaek, Herlinde Dumez, Maria De Santis, Christine Theodore, Michael Leahy, J.D. Chester, Antony Verbaeys, Armelle Caty, Gedske Daugaard, Sandrine Marreaud, Samantha Cambier, Richard Sylvester
Final Results of EORTC Intergroup Randomized Phase III Trial Comparing Immediate versus Deferred Chemotherapy after Radical Cystectomy in patients with pT3T4 and/or N+ M0 Transitional Cell Carcinoma of the Bladder.
In this largest reported randomized trial of adjuvant chemotherapy in patients with muscle invasive bladder cancer, immediate adjuvant cisplatin based combination chemotherapy led to a statistically significant improvement in progression-free survival, the secondary endpoint.
Abstract #LBA9008
Monday, 02 June, 17:12 – 17:24, E Arie Crown Theater
Alexander M. Eggermont, Vanna Chiarion-Sileni, Jean Jacques Grob, Reinhard Dummer, Jedd D. Wolchok, Henrik Schmidt, Omid Hamid, Caroline Robert, Paolo Antonio Ascierto, Jon M. Richards, Celeste Lebbe, Virginia Ferraresi, Michael Smylie, Jeffrey S. Weber, Michele Maio, Cyril Konto, Ravichandra Karra Gurunath, Veerle de Pril, Stefan Suciu, Alessandro Testori
Ipilimumab versus placebo after complete resection of stage III melanoma: Initial efficacy and safety results from the EORTC 18071 phase III trial.
This randomized, multicenter, double-blind phase III trial prospectively assessed the efficacy and safety of ipilimumab in patients who had undergone complete resection of stage III melanoma. At a median follow-up of almost three years, the primary analysis of recurrence-free survival will be presented. Safety data will also be presented.
Abstract #3501
Monday, 02 June, 8:12 – 8:24, E Arie Crown Theater
Hans-Joachim Schmoll, Karin Haustermans, Timothy Jay Price, Bernard Nordlinger, Ralf Hofheinz, Jean-Francois Daisne, Jozef Janssens, Baruch Brenner, Peter Schmidt, Hans Reinel, Stephan Hollerbach, Karel Caca, Florian W.B. Fauth, Carla Hannig, John Raymond Zalcberg, Niall C. Tebbutt, Murielle E. Mauer, Carlo G. M. Messina, Manfred P. Lutz, Eric Van Cutsem
Preoperative chemoradiotherapy and postoperative chemotherapy with capecitabine and oxaliplatin vs. capecitabine alone in locally advanced rectal cancer: Disease free survival results at interim analysis.
Interim results of this randomized trial indicate that the addition of oxaliplatin to capecitabine plus radiotherapy does not improve disease-free survival in patients with rectal adenocarcinoma.
Abstract #2003
Sunday, 01 June, 9:12 9:24, E450
Wolfgang Wick, Thierry Gorlia, Martin J. Van Den Bent, Charles J Vecht, Jonathan Steuve, Alba Ariela Brandes, Michael Platten, Markus A Kosch, Monika E. Hegi, Benoit Lhermitte, Vassilis Golfinopoulos, Mario Campone, Jean-Sebastien Frenel, Martin J.B. Taphoorn, Gianfranco A. Pesce, Patrick Roth
Radiation therapy and concurrent plus adjuvant temsirolimus (CCI-779)versus chemo-irradiation with temozolomide in newly diagnosed glioblastoma without methylation of the MGMT gene promoter.
The study concludes that the therapeutic activity of temsirolimus in patients with newly diagnosed glioblastoma with an unmethylated MGMT promoter is too low.
Poster Highlights Session
Abstract #2034
Friday, 30 May, 13:00 – 16:00, E354b, Poster Board #25
Divine Ewane Ediebah, Francisca Galindo-Garre, Bernard M.J. Uitdehaag, Jolie Ringash, Jaap C. Reijneveld, Linda Dirven, Efstathios Zikos, Corneel Coens, Martin J. Van Den Bent, Andrew Bottomley, Martin J.B. Taphoorn
Joint modeling of longitudinal health-related quality of life (HRQoL) data and survival.
The findings of this study suggest that part of the survival benefit of radiotherapy plus procarbazine, lomustine and vincristine chemotherapy can be masked by the negative effect that this treatment has on the patients’ health related quality of life.
General Poster Sessions
Abstract # 9067
Saturday, 31 May, 8:00 – 11:45. S Hall A2, poster board #271
Stefan Suciu, Natalie Ives, Alexander M. Eggermont, John M. Kirkwood, Paul Lorigan, Svetomir Markovic, Claus Garbe, Keith Wheatley
Predictive importance of ulceration on the efficacy of adjuvant interferon-a: An individual patient data meta-analysis of 15 randomized trials in > 7500 melanoma patients.
This meta-analysis provides evidence that adjuvant interferon significantly reduces the risk of relapse and improves overall survival. It did not identify the optimal dose or duration of interferon, and the overall survival benefit was confined to patients with ulcerated tumors.
Abstract #10579
Monday, 02 June, 8:00 – 11:45, S Hall A2, Poster Board #287
Isabelle Laure Ray-Coquard, Stefan Sleijfer, Saskia Litière, Jean-Yves Blay, Axel Le Cesne, Zsuzsanna Papai, Ian Robert Judson, Patrick Schoffski, Sant P. Chawla, Thierry Gil, Sophie Piperno-Neumann, Sandrine Marreaud, Rachel Hodge, Winette T.A. Van Der Graaf
Pazopanib in uterine sarcoma: Review of two EORTC & GSK clinical trials 62043 and 62072 on pazopanib for soft tissue sarcoma.
Pazopanib shows similar efficacy in uterine sarcomas and non-uterine sarcomas. Median overall survival for uterine sarcoma is longer compared to other subtypes in this small group.
Abstract #9570
Sunday, 01 June, 8:00 – 11:45. S Hall A2, Poster Board #220
Efstathios Zikos, Corneel Coens, Miriam Sprangers, Eva Greimel, Irina Ghislain, Divine Ewane Ediebah, Henning Flechtner, Andrew Bottomley
Has health-related quality of life assessment in EORTC clinical trials helped to obtain regulatory approvals and change clinical practice? A review of the EORTC experience in cancer clinical trials.
This review demonstrates the major importance of the patient perspective in palliative and curative trials in oncology. It demonstrates how recent findings in EORTC randomized clinical trials have altered clinical practice.
Abstract #TPS659
Monday, 02 June, 8:00 – 11:45, S Hall A2, Poster Board #119B
Tryfonidis K., Bogaerts J., Martell R., Sledge G., Balmana J., Audeh W., Deleersnijder A., Favorito F., Agarwal S., Rizzetto G., Messina C., Slaets L., Goulioti T., Tutt A., Cameron D., Turner N.
A phase III randomized trial of niraparib versus physician’s choice in previously- treated, HER2 negative, germline-BRCA mutated breast cancer patients: Intergroup study EORTC-1307-BCG and BIG5-13.
This trial is currently enrolling patients in Europe, North America, and Israel and is sponsored by TESARO.
INFORMATION: END
EORTC to present cancer research results at ASCO 2014
2014-05-21
ELSE PRESS RELEASES FROM THIS DATE:
The Net Children Go Mobile Project launches its report at the ICA 64th Annual Conference
2014-05-21
Washington, DC (May 21, 2014) The Net Children Go Mobile project will release new data on children's mobile use at the 64th Annual Conference of the International Communication Association at the Seattle Sheraton hotel. The project found that 46% of children own a smartphone and 41% use it daily to go online, while 20% own a tablet but 23% use it on a daily basis to access the Internet. Smartphone and tablet users engage more in communication and entertainment activities. They also have a higher level of digital skills, safety skills, and communicative abilities. However, ...
A star cluster in the wake of Carina
2014-05-21
NGC 3590 is a small open cluster of stars around 7500 light-years from Earth, in the constellation of Carina (The Keel). It is a gathering of dozens of stars loosely bound together by gravity and is roughly 35 million years old.
This cluster is not just pretty; it is very useful to astronomers. By studying this particular cluster — and others nearby — astronomers can explore the properties of the spiral disc of our galaxy, the Milky Way. NGC 3590 is located in the largest single segment of a spiral arm that can be seen from our position in the galaxy: the Carina spiral ...
Study shows iron from melting ice sheets may help buffer global warming
2014-05-21
A newly-discovered source of oceanic bioavailable iron could have a major impact our understanding of marine food chains and global warming. A UK team has discovered that summer meltwaters from ice sheets are rich in iron, which will have important implications on phytoplankton growth. The findings are reported in the journal Nature Communications on 21st May, 2014*.
It is well known that bioavailable iron boosts phytoplankton growth in many of the Earth's oceans. In turn phytoplankton capture carbon – thus buffering the effects of global warming. The plankton also feed ...
More maternal mental health surveillance is needed, suggests new study
2014-05-21
Maternal depression is more common at four years following childbirth than at any other time in the first 12 months after childbirth, and there needs to be a greater focus on maternal mental health, suggests a new study published today (21 May) in BJOG: An International Journal of Obstetrics and Gynaecology.
The study using data from 1507 women from six public hospitals in Melbourne, Australia, examines the prevalence of maternal depression from early pregnancy to four years postpartum. The researchers identify the possible risk factors for depressive symptoms at four ...
Molecule linked to aggressive pancreatic cancer offers potential clinical advances
2014-05-21
JACKSONVILLE, Fla. — Mayo Clinic researchers have discovered an enzyme they say is tightly linked to how aggressive pancreatic cancer will be in a patient.
They say the study, published in Molecular Cancer Research, provides key insights into the most aggressive form of the disease, which is one of the deadliest human cancers.
It also offers a number of possible future clinical advances, such as a way to gauge outcome in individual patients, and insight into potential therapy to shut down activity of the enzyme, known as Rac1b.
"The implication from our research is ...
A quicker way to determine who's faking it on the Internet
2014-05-21
Researchers at the University of Montreal have developed an improved chemical analysis method that is more efficient and faster in detecting counterfeit medicines, which have skyrocketed in recent years. The method was developed and tested in a study by Philippe Lebel, Alexandra Furtos and Karen Waldron of the university's Department of Chemistry. It identifies and quantifies the various compounds present in a pharmaceutical product, in a fifth of the time it takes governmental services to do the same job. "Fake drugs are a scourge for public health," says Lebel. Once a ...
Compound reverses symptoms of Alzheimer's disease in mice, SLU research shows
2014-05-21
ST. LOUIS -- A molecular compound developed by Saint Louis University scientists restored learning, memory and appropriate behavior in a mouse model of Alzheimer's disease, according to findings in the May issue of the Journal of Alzheimer's Disease.
The molecule also reduced inflammation in the part of the brain responsible for learning and memory.
The paper, authored by a team of scientists led by Susan Farr, Ph.D., research professor of geriatrics at Saint Louis University, is the second mouse study that supports the potential therapeutic value of an antisense compound ...
Vitamin E in canola and other oils hurts lungs
2014-05-20
CHICAGO --- A large new Northwestern Medicine® study upends our understanding of vitamin E and ties the increasing consumption of supposedly healthy vitamin E-rich oils -- canola, soybean and corn – to the rising incidence of lung inflammation and, possibly, asthma.
The new study shows drastically different health effects of vitamin E depending on its form. The form of Vitamin E called gamma-tocopherol in the ubiquitous soybean, corn and canola oils is associated with decreased lung function in humans, the study reports. The other form of Vitamin E, alpha-tocopherol, ...
Researchers test whether Red Queen hypothesis makes species resilient
2014-05-20
In Lewis Carroll's 1871 classic novel Through the Looking Glass, the Red Queen tells Alice: "Now, here, you see, it takes all the running you can do, to keep in the same place."
Over the years, evolutionary biologists have used the Red Queen's statement to refer to the "Red Queen" hypothesis, which describes how living organisms, including humans, manage to survive in a changing environment by adapting through sexual reproduction. According to a University of Iowa researcher, the hypothesis is supported.
In a paper published in the journal Biology Letters, lead author ...
Shale development generally helps local government coffers
2014-05-20
Oil and gas development from shale fields has generally helped the public finances of local communities, providing new revenues and resources that usually -- but not always -- outweigh the increased demand for public services and other costs, according to a new analysis from two Duke University researchers.
Daniel Raimi and Richard Newell gathered data from communities surrounding 10 oil and gas "plays" from September 2013 through February 2014, traveling to Arkansas, Colorado, Louisiana, Montana, North Dakota, Pennsylvania, Texas and Wyoming to interview local officials ...